The African healthcare market holds significant potential. However, internally, Africa suffers from a scarcity of healthcare resources and a lack of independent development capabilities, largely relying on imports. African countries are now placing greater emphasis on the development of the healthcare industry and enhancing their local capabilities, which presents opportunities for global healthcare providers and pharmaceutical companies to enter the African market. Among them, Chinese healthcare enterprises have also made their presence felt.
Many well-known Chinese pharmaceutical and medical device enterprises have recognized the potential of the African market and have already entered and gradually expanded their businesses. For instance, Fosun Pharma's anti-malaria products have gained widespread recognition in Africa. Wuhan Humanwell Healthcare Group also has an extensive business layout in Africa and plans to further expand its production and commercial activities.
While there are numerous opportunities, Chinese healthcare enterprises also face challenges when entering and operating in the African market. On one hand, the political, economic, and social instability factors within African countries have a significant impact on the normal operation of enterprises. On the other hand, there are also commercial obstacles brought about by different market environments.
The African healthcare market is of a considerable scale. According to data from the World Economic Forum, the annual market size of vaccines and drugs in Africa exceeds $50 billion. A report by the United Nations Economic Commission for Africa (UNECA) estimates that by 2030, the business opportunities in the healthcare and wellness sectors in Africa are expected to reach a value of $259 billion.
With the growth of the African population and the increase in the elderly population, the African healthcare market will demonstrate even greater potential. It is projected that by 2050, the population of Africa will increase from 1.2 billion in 2019 to 2.5 billion. The impact of non-communicable diseases will expand accordingly, and by 2030, the number of deaths caused by non-communicable diseases will account for nearly 50% of the total number of deaths. At the same time, infectious diseases such as tuberculosis and HIV will still have a long-term impact on the African continent.
Despite the large scale of the healthcare market, the demand for healthcare services and drugs in Africa remains unmet. In many African countries, there is a shortage of healthcare professionals, medical facilities, diagnostic tools, and essential medicines, posing challenges in providing timely and effective healthcare services. In most sub-Saharan countries, more than 20% of the population lives more than two hours away from basic medical services. Especially in rural areas, access to high-quality medical services remains limited, leading to uneven quality of medical services and high mortality rates. Healthcare expenditure in sub-Saharan Africa is still lower than the average level of low- and middle-income countries and also lags behind the world average.
In stark contrast, in most developed countries with abundant healthcare system resources, the majority of people can easily access medical services, often through multiple healthcare channels.
